Ep. 154: DICE Therapeutics CEO Kevin Judice, Brunswick, Chegg

The Drill Down

EpisodeMay 4, 202244m

Ep. 154: DICE Therapeutics CEO Kevin Judice, Brunswick, Chegg

The Drill Down

EpisodeMay 4, 202244m

DICE Therapeutics CEO Kevin Judice, PhD., (DICE), explains the company’s focus on democratizing skin disease therapies. Brunswick (BC) says the business is doing well… but is anyone listening? Chegg (CHGG) sounds the alarm about the current state of higher education in the U.S. The Drill Down with Cory Johnson offers a regular look at the business stories behind stocks on the move. Learn more about your ad choices. Visit megaphone.fm/adchoices

Top comments

The Drill Down is a daily podcast focused on business fundamentals of the biggest stock movers of the market day, hosted by veteran financial journalist Cory Johnson. Through insightful interviews with CEOs and investors, meaningful research and in-depth analysis, The Drill Down provides a clearer picture of what’s really going on under the hood at publicly traded companies. This is business news for business people.

Switch to the Fountain App

Open in Fountain